Regional Tech Transfer BioHealth Innovation serves as a regional intermediary accelerating technology transfer and commercialization of federal lab and university research. This positions BHI as a primary source of deal flow and licensing opportunities for biotech startups, corporate partners, and investors in the DMV region. Sales opportunities include deal sourcing services, licensing facilitation, in region market analysis, and access to a vetted pipeline of technology transfer projects.

EIR Partnership Recent hires of Entrepreneurs-in-Residence indicate an active program to incubate startups and advance founders. This creates opportunities to offer sponsored EIR backed ventures, consulting engagements, or co development programs, with BHI as a channel to access high potential bioscience ventures.

Strategic Alliances BHI already pursues partnerships with Georgetown, GTV, CureTeQ and Big4Bio, signaling a strong strategic network and access to capital and commercialization pipelines. Potential sales angles include partnership management services, co innovation programs, market due diligence for ventures, and joint go to market initiatives with large ecosystem players.

Ecosystem Growth BHI’s mission to build an entrepreneurial ecosystem and strengthen local talent supply creates demand for workforce development, internships, and corporate training services. Offerings could include ongoing training programs, talent placement, and university collaboration packages to attract and retain biohealth startups in the DMV region.

Funding and Commercialization With revenue in the 10 to 25 million range and a nonprofit private public model focused on risk capital access, BHI is positioned to broker and structure commercialization deals, licensing, and co development funding with corporate partners and investors. Sales opportunities include sponsorships, membership programs, and consulting on technology transfer, regulatory strategy, and market readiness to accelerate portfolio companies.